Literature DB >> 11223030

Making decisions through Myc.

S Nasi1, R Ciarapica, R Jucker, J Rosati, L Soucek.   

Abstract

c-Myc is a transcriptional regulator involved in carcinogenesis through its role in growth control and cell cycle progression. Here we attempt to relate its role in stimulating the G1-S transition to the ability to affect functioning of key cell cycle regulators, and we focus on how its property of modulating transcription of a wide range of target genes could explain its capacity to affect multiple pathways leading to proliferation, apoptosis, growth, and transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223030     DOI: 10.1016/s0014-5793(01)02118-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  35 in total

1.  Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Chapla Agarwal; Rana P Singh; Rajesh Agarwal
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  APSES proteins regulate morphogenesis and metabolism in Candida albicans.

Authors:  Thomas Doedt; Shankarling Krishnamurthy; Dirk P Bockmühl; Bernd Tebarth; Christian Stempel; Claire L Russell; Alistair J P Brown; Joachim F Ernst
Journal:  Mol Biol Cell       Date:  2004-07       Impact factor: 4.138

3.  RACK1 regulates G1/S progression by suppressing Src kinase activity.

Authors:  Vidya Mamidipudi; Jian Zhang; Kelly C Lee; Christine A Cartwright
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

4.  Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.

Authors:  Robert V Brown; Forest L Danford; Vijay Gokhale; Laurence H Hurley; Tracy A Brooks
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

5.  Sequence signatures and the probabilistic identification of proteins in the Myc-Max-Mad network.

Authors:  William R Atchley; Andrew D Fernandes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

6.  Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

Authors:  Chuanbing Zang; Marlies Wächter; Hongyu Liu; Maximilian G Posch; Martin H Fenner; Christine Stadelmann; Andreas von Deimling; Kurt Possinger; Keith L Black; H Phillip Koeffler; Elena Elstner
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

7.  Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.

Authors:  H Liu; H Qiu; Y Song; Y Liu; H Wang; M Lu; M Deng; Y Gu; J Yin; K Luo; Z Zhang; X Jia; G Zheng; Z He
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

8.  c-MYC apoptotic function is mediated by NRF-1 target genes.

Authors:  Fionnuala Morrish; Christopher Giedt; David Hockenbery
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

9.  Differential gene regulation by the SRC family of coactivators.

Authors:  Hua Zhang; Xia Yi; Xiaojing Sun; Na Yin; Bin Shi; Huijian Wu; Dan Wang; Ge Wu; Yongfeng Shang
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

10.  C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?

Authors:  L Boldrini; R Bartoletti; M Giordano; F Manassero; C Selli; M Panichi; L Galli; F Farci; P Faviana
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.